William Wade Brooke's most recent trade in MaxCyte Inc was a trade of 50,000 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Aug. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | William Wade Brooke | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 13 Aug 2025 | 50,000 | 150,879 | - | 1.3 | 64,500 | Common Stock |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 50,790 | 50,790 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 29,210 | 100,879 | - | 0 | Common Stock | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 40,701 | 40,701 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | William Wade Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 21,367 | 71,669 | - | 0 | Common Stock |